Individualized cancer treatment

DNAWe work with the prediction of pharmacokinetics of new targeted treatments (eg erlotinib and dabrafenib) and side effects of classical chemotherapy especially in the treatment of lung cancer (gemcitabine and carboplatin), ovarian and breast cancer (paclitaxel / docetaxel and carboplatin) and pancreatic cancer (Nab-paclitaxel and gemcitabine).

ResearchersShow/Hide content

Research GroupShow/Hide content